{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T09:13:05Z","timestamp":1694855585259},"reference-count":12,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1111\/add.14462","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T04:50:03Z","timestamp":1540183803000},"page":"189-190","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extended\u2010release injectable naltrexone (XR\u2010NTX): a response to clinical issues raised by Brewer & Streel"],"prefix":"10.1111","volume":"114","author":[{"given":"Brantley P.","family":"Jarvis","sequence":"first","affiliation":[{"name":"Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"August F.","family":"Holtyn","sequence":"additional","affiliation":[{"name":"Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrinidhi","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Department of Psychology and Child Development California State University, Stanislaus  Turlock CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Andrew","family":"Tompkins","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of California San Francisco School of Medicine Ringgold standard institution  San Francisco CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel A.","family":"Oga","sequence":"additional","affiliation":[{"name":"Center for Applied Public Health Research RTI International  Rockville MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Bigelow","sequence":"additional","affiliation":[{"name":"Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Silverman","sequence":"additional","affiliation":[{"name":"Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14448"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14180"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/135562102200120479"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2005.0007"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/1355621031000117446"},{"key":"e_1_2_3_7_1","unstructured":"Alkermes Inc.Prescribing information for Vivitrol\u00ae (naltrexone for extended\u2010release injectable suspension).2015. Available at:https:\/\/www.vivitrol.com\/content\/pdfs\/prescribing\u2010information.pdf(accessed 18 September 2018) (Archived athttp:\/\/www.webcitation.org\/73MHdWrKY)."},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"e_1_2_3_9_1","unstructured":"Food and Drug Administration.Opioid use disorder: endpoints for demonstrating effectiveness of drugs for medication\u2010assisted treatment guidance for industry.2018. Available at:https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM615743.pdf(accessed 18 September 2018) (Archived athttp:\/\/www.webcitation.org\/73MHhTrVi)."},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03473.x"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.05.030"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505409"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380\u2010018\u20100094\u20105"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.14462","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.14462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:28:18Z","timestamp":1694780898000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.14462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1111\/add.14462"],"URL":"https:\/\/doi.org\/10.1111\/add.14462","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,30]]},"assertion":[{"value":"2018-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}